Sponsor
DMCA
Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26
India's pharmaceutical sector is projected to experience an 11% year-on-year growth in sales and EBITDA for Q1 FY26, driven by strong market performance across various regions. The hospital segment is expected to lead with a 17% growth, while diagnostics firms anticipate a 14% sales increase. Government initiatives and investments in R&D further support the industry's optimistic outlook.
English
नेपाली
हिन्दी
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek
Arabic
French
অসমীয়া
বাংলা